EpiValley Purchase Another Epitaxy Reactor from AIXTRON

AIXTRON AG today announced it had received a further repeat order from EpiValley Co., Ltd., headquartered in Kwangju City, South Korea in the second quarter of 2007. Epivalley, a long-term AIXTRON customer purchased three new Thomas Swan Close Coupled Showerhead (CCS) CRIUS production epitaxy reactors. The three CRIUS systems with a capacity of 30x2” will be dedicated to the manufacture of high brightness gallium nitride (GaN) based epitaxial wafers for the production of side-view LEDs.

Dr. D.J. Park, president and CEO of EpiValley Co., Ltd., said: "We have been very happy with our first Thomas Swan CCS CRIUS MOCVD tool which was commissioned and providing us with wafers in a very short time. Now that our customers are ramping up their production of side-view LEDs we must quickly increase wafer throughput. Therefore we decided to place this triple order. With all four CRIUS systems in place we will be able to satisfy the twin requirements of performance and price for the vast LED back-light unit (BLU) and solid-state lighting market."

EpiValley, manufacturer of epiwafers for blue, green, and UV LED and LED chips was the first to commission the CCS CRIUS system – one of the world’s most productive MOCVD systems for production of GaN-based LEDs and was among the first companies world-wide to produce high brightness blue LED epi-wafers on the CRIUS tool as reported by AIXTRON before.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.